Innovation Pharmaceuticals Inc (IPIX)

[iclight]

I don't disagree with anything you said except disagreeing with me on the PR point. The company did after all PR a spleen lesion disappearing.

I understand why they PRed the thymoma case, I just don't find it THAT intriguing as it's a very rare disease that seems to respond well to combo SOC treatments as I showed in the chart when I first posted. I know this one doesn't but from a "monetizing K" standpoint the PR didn't do much for me. To each his own.

We are on the same page with regard to releasing data in PRs vs peer reviewed articles and conferences.

I'm well aware of emerging biotechs and the results of releasing data early via PR. Happened with MD Anderson with a stock whose board you were previously a moderator. Not my first rodeo.